Abstract
Diabetes is one of the most common diseases and is one of the main causes of morbidity and mortality in world. The number of diabetic patients showed a sharp rise from 347 million to 400 million in seven years (2008 to 2015). India is one of the frontrunner countries in harbouring this disease. Herbal drugs are always been intriguing for the treatment of diabetes. Several polyherbal formulations, single drugs have been assigned to possess anti-diabetic potentials. Among the plant families, Orchidaceae is not only one of the most interesting, also have been praised for their medicinal values since ages. This review tries to encompass the uses of orchids in diabetes and related disorders. Nearly 19 species belonging to 12 genera of orchids are traditionally used in treating Diabetes and related pathophysiological conditions across the Globe. Some of them, if validation is concerned, are proven experimentally to show anti-diabetic and antihyperglycaemic potentials on standard animal models. Pharmacological studies revealed that as many as 17 species included in 6 genera of orchids are evaluated so far for anti-diabetic potential. With forbidden gaps in the traditional belief and pharmacological profile currently, there remains indeed a potential area for bio-prospecting of orchid group for their ant-diabetic property.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
